CB2 Receptor as Emerging Anti-Inflammatory Target in Duchenne Muscular Dystrophy.

There is a significant decrease in IL-6 production ( Figure 4 A) and an evident trend in the increase of the production of IL-10 ( Figure 4 B) pro- and anti-inflammatory molecules, respectively.

also in 268 other papers